News

TCL CSOT Unveils Game-Changing Display Technologies for Mobile Devices

TCL CSOT Unveils Game-Changing Display Technologies for Mobile Devices

Innovative Mobile Display Solutions by TCL CSOT

TCL CSOT, a well-respected leader in display technology for over 15 years, proudly introduced remarkable mobile display innovations at the Mobile World Congress 2025. Under its newly launched TCL CSOT APEX brand, these advancements highlight APEX's core principles: an enjoyable display experience, commitment to vision health, sustainability, and boundless imagination for the future. This showcase promises to enhance visual experiences in upcoming smart devices for users everywhere.

Commitment to Innovation

"We strive to maintain our position at the forefront of innovation, providing consumers with the very best in visual experiences," stated Jun Zhao, the Chief Executive Officer of TCL CSOT. This dedication was evident at MWC 2025, where TCL CSOT exhibited its commitment to delivering exceptional display technology characterized by stunning image quality and a sustainable approach.

Breakthrough Display Technologies

The 14-inch Camera-Under-Panel OLED Display

TCL CSOT introduced the world's first 14-inch laptop screen featuring Camera-Under-Panel (CUP) technology, perfectly designed to eliminate cutouts or notches for the webcam. This significant evolution means users can fully immerse themselves in their activities with less distraction. Featured in the Lenovo Yoga Slim 9i, this cutting-edge display boasts a remarkable 98% screen-to-body ratio.

Revolutionary Low-Power Display

This innovative low-power display measures 6.36 inches and stands out for its ability to deliver exceptional visuals while minimizing battery drain in mobile devices. TCL CSOT's cutting-edge multiple frequency partition technology enables the screen to function in three sections, each supporting varied refresh rates, effectively decreasing overall power consumption by up to 31%.

Eye-Protective WQHD Display

The 6.67-inch WQHD display features circularly polarized light technology designed to minimize glare, boost contrast, and enhance visibility outdoors. By integrating global DC dimming technology, it significantly reduces screen flickering, which helps minimize eye strain during prolonged usage.

Advanced Multiple Frequency Partitioned OLED Display

The 6.73-inch display combines stunning visual quality and eye care by allowing three partitions to operate concurrently. This innovation results in a significant reduction of driver IC power consumption by up to 20%. It achieves an impressive 96% screen-to-body ratio and a remarkable brightness of 3,200 nits. Additionally, it features 1,920Hz PWM dimming, ensuring a flicker-free viewing experience.

Biomimetic Eye Care Tablet Display

TCL CSOT also presented a 12.1-inch moth-eye biomimetic display designed specifically for tablets. This model boasts an array of features, including anti-glare, anti-reflective, anti-fingerprint, and anti-microbial properties, greatly enhancing visual clarity and hygiene. By mimicking natural light, it allows users to view content clearly, even in bright conditions, while its low blue light ratio helps reduce eye strain.

4K 144Hz AI Tablet Display

Additionally, TCL CSOT's cutting-edge 13-inch display showcases 4K resolution with a refresh rate of 144Hz, providing vibrant colors and crystal-clear details. The strategic multiple frequency partition technology and AI-driven adjustments optimize power consumption, resulting in a reduction of 21% compared to older technologies, ensuring a responsive experience when using styluses.

About TCL CSOT

Founded in 2009, TCL China Star Optoelectronics Technology Co., Ltd. (TCL CSOT) has established itself as a global trailblazer in display innovation. With a comprehensive array of technologies including LCD, OLED, and MLED, its products cater to diverse applications such as TVs, mobile devices, laptops, and commercial displays. TCL CSOT's robust R&D capabilities, supported by 11 production lines, further underline its commitment to crafting high-quality display solutions. As a key player in TCL’s partnership with the Olympics through 2032, TCL CSOT aims to elevate the Olympic experience with its display technology.

Frequently Asked Questions

What new innovations did TCL CSOT showcase at MWC 2025?

TCL CSOT revealed several groundbreaking mobile display technologies including the world's first Camera-Under-Panel OLED display and advanced low-power screens.

How does the Camera-Under-Panel technology improve user experience?

This technology allows for a more immersive experience by eliminating distractions from webcam notches, allowing for uninterrupted viewing.

What is the focus of TCL CSOT’s latest display innovations?

The innovations prioritize user experience, vision health, sustainability, and the goal of creating exceptional visual experiences in modern devices.

How does the 6.67-inch eye protection display benefit users?

It reduces glare and enhances visibility in bright conditions while minimizing screen flickering to help reduce eye strain.

What are the features of TCL CSOT's biomimetic eye care tablet display?

It offers advanced anti-glare, anti-reflective, and anti-fingerprint features, mimicking natural light for improved visual comfort.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 24

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 33

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 28

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 18

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 37

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 46

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 30

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Gene-Editing Therapy CS-121 Revolutionizes Hyperlipidemia Treatment

Updated Category News Views 232

Transformative Progress in Gene-Editing Therapies CorrectSequence Therapeutics Co., Ltd. is at the forefront of biotechnology innovation with its promising gene-editing therapy, CS-121, designed to tackle chylomicronemia and hypertriglyceridemia. This breakthrough comes as an exciting advancement in the medical field, particularly for patients suffering from severe lipid...

Continue Reading
Blue Ridge Partners Showcases Expertise at PEI Forum Europe

Updated Category News Views 211

Blue Ridge Partners Takes Center Stage at Key Forum Blue Ridge Partners, a leading global management consultancy, will serve as the Knowledge Partner for a significant upcoming event in the private equity sector. The firm is excited to announce its role in the 2025 PEI Operating Partners Forum Europe, taking place in May. Over a decade of collaboration as the Knowledge...

Continue Reading
Alger Russell Innovation Index Q4 2025 Rebalancing Insights

Updated Category News Views 81

Alger Russell Innovation Index Changes for Q4 2025 Fred Alger Management, LLC, a notable growth equity investment manager, has announced significant updates to the Alger Russell Innovation Index. This announcement concerns the quarterly rebalancing that will take place after the trading session concludes. These changes reflect the ever-evolving landscape of investment...

Continue Reading
Partners Value Split Corp. Announces Redemption of Shares

Updated Category News Views 205

Partners Value Split Corp. to Redeem Class AA Preferred Shares Recently, Partners Value Split Corp. (the “Company”) shared exciting news regarding its Class AA Preferred Shares, Series 9. This announcement indicates the Company’s intention to redeem all of its outstanding 5,996,800 Preferred Shares, Series 9 for cash, in accordance with the established terms....

Continue Reading
Pagos' MCP Server: The Future of Payment Data Access?

Updated Category News Views 160

Pagos unveiled a significant upgrade to its Model Context Protocol (MCP) Server on February 17, 2026. This expansion aims to revolutionize how merchants access and analyze their verified payments data directly via AI chat agents like ChatGPT and Claude. Traders in the fintech space are already sizing up this move, pondering whether it marks a genuine leap forward or just...

Continue Reading